Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
572 Leser
Artikel bewerten:
(2)

Wearable Health Solutions, Inc.: Castle Placement Named Exclusive Placement Agent for Wearable Health Solutions Inc.

Castle Placement As Its Exclusive Placement Agent To Raise $5 Million To Fund Business Development/Growth For The Pivotal Product Launch Of Company's iHelp MAX Medical Alert/Medical Monitoring Device

NEW YORK, NY / ACCESSWIRE / October 6, 2021 / Wearable Health Solutions Inc. (OTC PINK:WHSI), a manufacturer of multiple lines of proprietary personal medical devices, tracking devices, and wearable health technology monitored and managed through its fully-developed tracking and automation platform, announced today that it has engaged Castle Placement as its exclusive placement agent to raise $5 million to fund business development/growth for the pivotal product launch of the Company's iHelp MAX device.

Wearable Health Solutions Inc. is a personal monitoring technology developer focused on mobile alert and tracking devices for emergency medical and occupational safety markets worldwide. WHSI generates revenues from the sale of its medical alarm devices and recurring service fees based on monitoring subscription plans. In addition to the U.S. and Canada, which contribute a vast majority of the Company's business volume, WHSI has also sold its solutions across several continents, including in countries such as New Zealand, Denmark, Ireland, Brazil, Barbados, Bermuda and the People's Republic of China.

Peter Pizzino, the President of Wearable Health Solutions Inc. said: "The iHelp MAX product is the latest in mobile Personal Emergency Response Systems (mPERS), and the partnership between WHSI and Castle is designed to capitalize on the growing need for real-time location tracking, emergency alert services, and real-time wearable health remote monitoring technologies."

About Castle Placement:

Founded in 2009, Castle Placement raises equity and debt capital for private middle market companies across a broad spectrum of industries. Highly experienced investment bankers and a robust, data-driven, innovative technology platform - including artificial intelligence/machine learning - match great companies with global institutional investors. Castle Placement's proprietary app, CPGO, connects companies with investors in real time. It has over 64,500 private equity, venture capital and strategic investors, family offices, pension funds, foundations, endowments, sovereign wealth funds, hedge funds, and lenders.

For more information go to https://castleplacement.com

About Wearable Health Solutions:

As a leader in the growing eHealth sector, we provide innovative wearable healthcare products, tracking services, and turn-key solutions that enable consumers to be proactive with their health, as well as safe and protected at all times. Our products and services are always state-of-the-art, innovative, and cost effective.

Our latest product, currently in development, is the iHelp MAX. The MAX device showcases improved features and functions including fall detection and geo-fencing (the ability to pre-set an area and alert loved ones if the device user enters or leaves a pre-determined area), and will be Wi-Fi and Bluetooth enabled, supporting our entrance into the remote medical monitoring and wearable health technology sector.

The advancement of wearable technology and growing demand from consumers to take control of their own health has generated a booming market, and demand for wearables is projected to jump over the next few years as more consumers exhibit interest in sharing their wearable data with providers and insurers. WHSI is uniquely positioned to fulfill this demand.

Forward-Looking Statements

Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as "continue," "will," "may," "could," "should," "expect," "expected," "plans," "intend," "anticipate," "believe," "estimate," "predict," "potential," and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Wearable Health Solutions and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to (i) Wearable Health Solutions ability (or inability) to obtain additional financing in sufficient amounts or on acceptable terms when needed; (ii) Wearable Health Solutions ability to maintain existing, and secure additional, contracts with users of its solutions; (iii) Wearable Health Solutions ability to successfully expand in existing markets and enter new markets; (iv) Wearable Health Solutions ability to successfully manage and integrate any acquisitions of businesses, solutions or technologies; (v) unanticipated operating costs, transaction costs and actual or contingent liabilities; (vi) the ability to attract and retain qualified employees and key personnel; (vii) adverse effects of increased competition on Wearable Health Solutions business; (viii) changes in government licensing and regulation that may adversely affect Wearable Health Solutions business; (ix) the risk that changes in consumer behavior could adversely affect Wearable Health Solutions business; (x) Wearable Health Solutions ability to protect its intellectual property; (xi) local, industry and general business and economic conditions. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent quarterly report on filed by Wearable Health Solutions with the Securities and Exchange Commission. Wearable Health Solutions anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Wearable Health Solutions assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

Wearable Health Solutions Inc.
2300 Yonge St. Suite 1600
Toronto, ONT M4P1E4
Canada
www.WearableHealthSolutions.com
855-226-4827
info@wearablehealthsolutions.com

SOURCE: Wearable Health Solutions Inc.



View source version on accesswire.com:
https://www.accesswire.com/666941/Castle-Placement-Named-Exclusive-Placement-Agent-for-Wearable-Health-Solutions-Inc

© 2021 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.